ID   SIK1_RAT                Reviewed;         776 AA.
AC   Q9R1U5; Q9R081;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   24-JUL-2024, entry version 175.
DE   RecName: Full=Serine/threonine-protein kinase SIK1;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:17939993};
DE   AltName: Full=Protein kinase KID2;
DE   AltName: Full=Salt-inducible kinase 1;
DE            Short=SIK-1;
DE   AltName: Full=Serine/threonine-protein kinase SNF1-like kinase 1;
DE            Short=Serine/threonine-protein kinase SNF1LK;
GN   Name=Sik1; Synonyms=Kid2, Sik, Snf1lk;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AUTOPHOSPHORYLATION, AND INDUCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Adrenal gland;
RX   PubMed=10403390; DOI=10.1016/s0014-5793(99)00708-5;
RA   Wang Z., Takemori H., Halder S.K., Nonaka Y., Okamoto M.;
RT   "Cloning of a novel kinase (SIK) of the SNF1/AMPK family from high salt
RT   diet-treated rat adrenal.";
RL   FEBS Lett. 453:135-139(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INDUCTION.
RX   PubMed=10820182; DOI=10.1046/j.1471-4159.2000.0742227.x;
RA   Feldman J.D., Vician L., Crispino M., Hoe W., Baudry M., Herschman H.R.;
RT   "The salt-inducible kinase, SIK, is induced by depolarization in brain.";
RL   J. Neurochem. 74:2227-2238(2000).
RN   [3]
RP   FUNCTION IN PHOSPHORYLATION OF PPME1, CATALYTIC ACTIVITY, PHOSPHORYLATION
RP   AT THR-322, MUTAGENESIS OF THR-322, AND INTERACTION WITH ATP1A1.
RX   PubMed=17939993; DOI=10.1073/pnas.0706838104;
RA   Sjostrom M., Stenstrom K., Eneling K., Zwiller J., Katz A.I., Takemori H.,
RA   Bertorello A.M.;
RT   "SIK1 is part of a cell sodium-sensing network that regulates active sodium
RT   transport through a calcium-dependent process.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:16922-16927(2007).
RN   [4]
RP   FUNCTION.
RX   PubMed=18946175; DOI=10.1507/endocrj.k08e-173;
RA   Takemori H., Katoh Hashimoto Y., Nakae J., Olson E.N., Okamoto M.;
RT   "Inactivation of HDAC5 by SIK1 in AICAR-treated C2C12 myoblasts.";
RL   Endocr. J. 56:121-130(2009).
RN   [5]
RP   FUNCTION IN PHOSPHORYLATION OF CRTC1, AND SUBCELLULAR LOCATION.
RX   PubMed=19244510; DOI=10.1523/jneurosci.2296-08.2009;
RA   Li S., Zhang C., Takemori H., Zhou Y., Xiong Z.Q.;
RT   "TORC1 regulates activity-dependent CREB-target gene transcription and
RT   dendritic growth of developing cortical neurons.";
RL   J. Neurosci. 29:2334-2343(2009).
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in various processes
CC       such as cell cycle regulation, gluconeogenesis and lipogenesis
CC       regulation, muscle growth and differentiation and tumor suppression.
CC       Phosphorylates HDAC4, HDAC5, PPME1, SREBF1, CRTC1/TORC1 and
CC       CRTC2/TORC2. Acts as a tumor suppressor and plays a key role in
CC       p53/TP53-dependent anoikis, a type of apoptosis triggered by cell
CC       detachment: required for phosphorylation of p53/TP53 in response to
CC       loss of adhesion and is able to suppress metastasis. Part of a sodium-
CC       sensing signaling network, probably by mediating phosphorylation of
CC       PPME1: following increases in intracellular sodium, SIK1 is activated
CC       by CaMK1 and phosphorylates PPME1 subunit of protein phosphatase 2A
CC       (PP2A), leading to dephosphorylation of sodium/potassium-transporting
CC       ATPase ATP1A1 and subsequent increase activity of ATP1A1. Acts as a
CC       regulator of muscle cells by phosphorylating and inhibiting class II
CC       histone deacetylases HDAC4 and HDAC5, leading to promote expression of
CC       MEF2 target genes in myocytes. Also required during cardiomyogenesis by
CC       regulating the exit of cardiomyoblasts from the cell cycle via down-
CC       regulation of CDKN1C/p57Kip2. Acts as a regulator of hepatic
CC       gluconeogenesis by phosphorylating and repressing the CREB-specific
CC       coactivators CRTC1/TORC1 and CRTC2/TORC2, leading to inhibit CREB
CC       activity. Also regulates hepatic lipogenesis by phosphorylating and
CC       inhibiting SREBF1. In concert with CRTC1/TORC1, regulates the light-
CC       induced entrainment of the circadian clock by attenuating PER1
CC       induction; represses CREB-mediated transcription of PER1 by
CC       phosphorylating and deactivating CRTC1/TORC1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q60670, ECO:0000269|PubMed:10820182,
CC       ECO:0000269|PubMed:17939993, ECO:0000269|PubMed:18946175,
CC       ECO:0000269|PubMed:19244510}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:17939993};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:17939993};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ACTIVITY REGULATION: Activated by phosphorylation on Thr-182 (By
CC       similarity). Also activated by phosphorylation on Thr-322 in response
CC       to increases in intracellular sodium in parallel with elevations in
CC       intracellular calcium through the reversible sodium/calcium exchanger.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts (when phosphorylated on Thr-182 and Ser-186) with
CC       YWHAZ (By similarity). Interacts with ATP1A1. {ECO:0000250,
CC       ECO:0000269|PubMed:17939993}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19244510}. Nucleus
CC       {ECO:0000269|PubMed:19244510}. Note=Following ACTH (adrenocorticotropic
CC       hormone) treatment and subsequent phosphorylation by PKA, translocates
CC       to the cytoplasm, where it binds to YWHAZ.
CC   -!- INDUCTION: By high salt diet and depolarization in brain.
CC       {ECO:0000269|PubMed:10403390, ECO:0000269|PubMed:10820182}.
CC   -!- DOMAIN: The RK-rich region determines the subcellular location.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated at Thr-182 by STK11/LKB1 in complex with STE20-
CC       related adapter-alpha (STRADA) pseudo kinase and CAB39, leading to its
CC       activation. Phosphorylation at Thr-182 promotes autophosphorylation at
CC       Ser-186, which is required for sustained activity. Autophosphorylation
CC       at Ser-186 is maintained by sequential phosphorylation at Thr-182 by
CC       GSK3-beta. GSK3-beta cannot initiate phosphorylation at Thr-182, it can
CC       only maintain it. Phosphorylation at Ser-577 by PKA promotes
CC       translocation to the cytoplasm (By similarity). Phosphorylation at Thr-
CC       322 by CaMK1 following intracellular sodium concentration leads to
CC       activation. {ECO:0000250, ECO:0000269|PubMed:17939993}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. AMPK subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB020480; BAA82673.1; -; mRNA.
DR   EMBL; AF106937; AAF14191.1; -; mRNA.
DR   RefSeq; NP_067725.2; NM_021693.2.
DR   AlphaFoldDB; Q9R1U5; -.
DR   SMR; Q9R1U5; -.
DR   DIP; DIP-46210N; -.
DR   IntAct; Q9R1U5; 1.
DR   STRING; 10116.ENSRNOP00000001579; -.
DR   iPTMnet; Q9R1U5; -.
DR   PhosphoSitePlus; Q9R1U5; -.
DR   PaxDb; 10116-ENSRNOP00000001579; -.
DR   Ensembl; ENSRNOT00000001579.7; ENSRNOP00000001579.3; ENSRNOG00000001189.7.
DR   Ensembl; ENSRNOT00055011236; ENSRNOP00055008810; ENSRNOG00055006839.
DR   Ensembl; ENSRNOT00060037614; ENSRNOP00060031008; ENSRNOG00060021707.
DR   GeneID; 59329; -.
DR   KEGG; rno:59329; -.
DR   UCSC; RGD:69407; rat.
DR   AGR; RGD:69407; -.
DR   CTD; 150094; -.
DR   RGD; 69407; Sik1.
DR   eggNOG; KOG0586; Eukaryota.
DR   GeneTree; ENSGT00940000154989; -.
DR   HOGENOM; CLU_000288_87_2_1; -.
DR   InParanoid; Q9R1U5; -.
DR   OrthoDB; 5475340at2759; -.
DR   PhylomeDB; Q9R1U5; -.
DR   TreeFam; TF315213; -.
DR   PRO; PR:Q9R1U5; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   Bgee; ENSRNOG00000001189; Expressed in lung and 18 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0071889; F:14-3-3 protein binding; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0008140; F:cAMP response element binding protein binding; ISS:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; ISO:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0043276; P:anoikis; ISO:RGD.
DR   GO; GO:0055007; P:cardiac muscle cell differentiation; ISS:UniProtKB.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:UniProtKB.
DR   GO; GO:0032792; P:negative regulation of CREB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0045721; P:negative regulation of gluconeogenesis; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0010868; P:negative regulation of triglyceride biosynthetic process; ISS:UniProtKB.
DR   GO; GO:2000210; P:positive regulation of anoikis; ISO:RGD.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0045595; P:regulation of cell differentiation; ISS:UniProtKB.
DR   GO; GO:0007346; P:regulation of mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0010830; P:regulation of myotube differentiation; ISS:UniProtKB.
DR   GO; GO:0002028; P:regulation of sodium ion transport; IDA:UniProtKB.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   CDD; cd14071; STKc_SIK; 1.
DR   CDD; cd14408; UBA_SIK1; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR017090; Ser/Thr_kinase_SIK1/2.
DR   InterPro; IPR034672; SIK.
DR   InterPro; IPR015940; UBA.
DR   PANTHER; PTHR24346; MAP/MICROTUBULE AFFINITY-REGULATING KINASE; 1.
DR   PANTHER; PTHR24346:SF47; NON-SPECIFIC SERINE_THREONINE PROTEIN KINASE-RELATED; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF037014; Ser/Thr_PK_SNF1-like; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Biological rhythms; Cell cycle; Cytoplasm;
KW   Developmental protein; Differentiation; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Tumor suppressor.
FT   CHAIN           1..776
FT                   /note="Serine/threonine-protein kinase SIK1"
FT                   /id="PRO_0000086661"
FT   DOMAIN          27..278
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          303..343
FT                   /note="UBA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00212"
FT   REGION          350..371
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          449..472
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          586..612
FT                   /note="RK-rich region"
FT                   /evidence="ECO:0000250"
FT   REGION          621..643
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        352..371
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        149
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         33..41
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         56
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         182
FT                   /note="Phosphothreonine; by LKB1 and GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:P57059"
FT   MOD_RES         186
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P57059"
FT   MOD_RES         322
FT                   /note="Phosphothreonine; by CaMK1"
FT                   /evidence="ECO:0000269|PubMed:17939993"
FT   MOD_RES         577
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:Q60670"
FT   MUTAGEN         322
FT                   /note="T->A: Abolishes ability to regulate
FT                   sodium/potassium-transporting ATPase activity following
FT                   increases in intracellular sodium."
FT                   /evidence="ECO:0000269|PubMed:17939993"
FT   CONFLICT        473
FT                   /note="R -> K (in Ref. 2; AAF14191)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   776 AA;  84909 MW;  7BF745AF28F17E6E CRC64;
     MVIMSEFSAV PTGTGQGQQK PLRVGFYDVE RTLGKGNFAV VKLARHRVTK TQVAIKIIDK
     TRLDSSNLEK IYREVQLMKL LNHPNIIKLY QVMETKDMLY IVTEFAKNGE MFDYLTSNGH
     LSENEARKKF WQILSAVEYC HNHHIVHRDL KTENLLLDGN MDIKLADFGF GNFYKPGEPL
     STWCGSPPYA APEVFEGKEY EGPQLDIWSL GVVLYVLVCG SLPFDGPNLP TLRQRVLEGR
     FRIPFFMSQD CETLIRRMLV VDPAKRITIA QIRQHRWMQA DPTLLQQDDP AFSMQGYTSN
     LGDYNEQVLG IMQALGIDRQ RTVESLQNSS YNHFAAIYYL LLERLREHRS TQPSSRATPA
     PARQPQLRNS DLSSLEVPQE ILPCDPFRPS LLCPQPQALA QSVLQAEIDC DLHSSLQPLF
     FPLDTNCSGV FRHRSISPSS LLDTAISEEA RQGPSLEEEQ EVQEPLPGST GRRHTLAEVS
     THFSPLNPPC IIVSSSAAVS PSEGTSSDSC LPFSASEGPA GLGGGLATPG LLGTSSPVRL
     ASPFLGSQSA TPVLQSQAGL GATVLPPVSF QEGRRASDTS LTQGLKAFRQ QLRKNARTKG
     FLGLNKIKGL ARQVCQSSIR GSRGGMSTFH TPAPSSGLQG CTASSREGRS LLEEVLHQQR
     LLQLQHHSAV SSDYQQAPQL SPVPYVLTPC DGLLVSGIPL LPTPLLQPGM SPVASAAQLL
     DAHLHISAGP VALPTGPLPQ CLTRLSPSCD PAGLPQGDCE MEDLTSGQRG TFVLVQ
//
